These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28390409)

  • 1. A child with resistant Kawasaki disease successfully treated with anakinra: a case report.
    Sánchez-Manubens J; Gelman A; Franch N; Teodoro S; Palacios JR; Rudi N; Rivera J; Antón J
    BMC Pediatr; 2017 Apr; 17(1):102. PubMed ID: 28390409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial).
    Tremoulet AH; Jain S; Kim S; Newburger J; Arditi M; Franco A; Best B; Burns JC
    Contemp Clin Trials; 2016 May; 48():70-5. PubMed ID: 27080929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anakinra And Etanercept Combination Treatment in a Child With Severe, Nonresponsive Kawasaki Disease.
    Walser M; Hermann M; Hufnagel M; Haas NA; Fischer M; Dalla-Pozza R; Jakob A
    Pediatr Infect Dis J; 2020 Oct; 39(10):e310-e313. PubMed ID: 32618930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II Open Label Study of Anakinra in Intravenous Immunoglobulin-Resistant Kawasaki Disease.
    Koné-Paut I; Tellier S; Belot A; Brochard K; Guitton C; Marie I; Meinzer U; Cherqaoui B; Galeotti C; Boukhedouni N; Agostini H; Arditi M; Lambert V; Piedvache C
    Arthritis Rheumatol; 2021 Jan; 73(1):151-161. PubMed ID: 32779863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: A retrospective cases series.
    Kone-Paut I; Cimaz R; Herberg J; Bates O; Carbasse A; Saulnier JP; Maggio MC; Anton J; Piram M
    Autoimmun Rev; 2018 Aug; 17(8):768-774. PubMed ID: 29885546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comprehensive Update on Kawasaki Disease Vasculitis and Myocarditis.
    Soni PR; Noval Rivas M; Arditi M
    Curr Rheumatol Rep; 2020 Feb; 22(2):6. PubMed ID: 32020498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kawasaki disease in Sicily: clinical description and markers of disease severity.
    Maggio MC; Corsello G; Prinzi E; Cimaz R
    Ital J Pediatr; 2016 Nov; 42(1):92. PubMed ID: 27806720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis.
    Gorelik M; Lee Y; Abe M; Andrews T; Davis L; Patterson J; Chen S; Crother TR; Aune GJ; Noval Rivas M; Arditi M
    Clin Exp Immunol; 2019 Oct; 198(1):101-110. PubMed ID: 31099056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anakinra Treatment in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysms: A Phase I/IIa Trial.
    Yang J; Jain S; Capparelli EV; Best BM; Son MB; Baker A; Newburger JW; Franco A; Printz BF; He F; Shimizu C; Hoshino S; Bainto E; Moreno E; Pancheri J; Burns JC; Tremoulet AH
    J Pediatr; 2022 Apr; 243():173-180.e8. PubMed ID: 34953816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anakinra for Treatment-Resistant Kawasaki Disease: Evidence from a Literature Review.
    Ferrara G; Giani T; Caparello MC; Farella C; Gamalero L; Cimaz R
    Paediatr Drugs; 2020 Dec; 22(6):645-652. PubMed ID: 32885390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Immunological Axis Involving Interleukin 1β and Leucine-Rich-α2-Glycoprotein Reflects Therapeutic Response of Children with Kawasaki Disease: Implications from the KAWAKINRA Trial.
    Kessel C; Koné-Paut I; Tellier S; Belot A; Masjosthusmann K; Wittkowski H; Fuehner S; Rossi-Semerano L; Dusser P; Marie I; Boukhedouni N; Agostini H; Piedvache C; Foell D
    J Clin Immunol; 2022 Aug; 42(6):1330-1341. PubMed ID: 35699824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting Kawasaki disease: a state-of-the-art review.
    Dietz SM; van Stijn D; Burgner D; Levin M; Kuipers IM; Hutten BA; Kuijpers TW
    Eur J Pediatr; 2017 Aug; 176(8):995-1009. PubMed ID: 28656474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted use of prednisolone with the second IVIG dose for refractory Kawasaki disease.
    Kimura M; Harazaki M; Fukuoka T; Asakura I; Sakai H; Kamimaki T; Ohkawara I; Akiyama N; Tsurui S; Iwashima S; Shimomura M; Morishita H; Meguro T; Seto S
    Pediatr Int; 2017 Apr; 59(4):397-403. PubMed ID: 27743415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylprednisolone pulse therapy for massive lymphadenopathy in a child with intravenous immunoglobulin-resistant Kawasaki disease.
    Chen HH; Liu PM; Bong CN; Wu YT; Yang KD; Wang CL
    J Microbiol Immunol Infect; 2005 Apr; 38(2):149-52. PubMed ID: 15843862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kawasaki disease: what you need to know].
    Bajolle F; Laux D
    Arch Pediatr; 2012 Nov; 19(11):1264-8. PubMed ID: 22921712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of Giant Coronary Aneurisms in a Child With Refractory Kawasaki Disease Treated With Anakinra.
    Gambacorta A; Buonsenso D; De Rosa G; Lazzareschi I; Gatto A; Brancato F; Pata D; Valentini P
    Front Pediatr; 2020; 8():195. PubMed ID: 32457855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunoglobulin therapy].
    Ogata S; Ishii M
    Nihon Rinsho; 2014 Sep; 72(9):1617-22. PubMed ID: 25518412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
    Sato S; Kawashima H; Kashiwagi Y; Hoshika A
    Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kawasaki disease: a comprehensive review of treatment options.
    Patel RM; Shulman ST
    J Clin Pharm Ther; 2015 Dec; 40(6):620-5. PubMed ID: 26547265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.